ARCHIVES

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 17 | May 2, 2008

Download PDF Visit The Full Archive

Related Articles

City of Hope Selects Michael Friedman As President, CEO

May 16, 2003

In Brief: Cancer Program “Greatest Experiment And it Works,” ACS President tells Congress

June 25, 1976

Hilton Head, SC, Physician’s Files Subpoenaed By FBI

March 18, 1994

Pauling Contends His Applications Included Essentials

April 27, 1979

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974

Review Of NTP Could Lead To Administrative Changes

April 18, 1980